MA26612A1 - Pyrazolopyrimidines et pyrazolotriazines - Google Patents

Pyrazolopyrimidines et pyrazolotriazines

Info

Publication number: MA26612A1
Authority: MA; Morocco
Prior art keywords: pyrazolotriazines; pyrazolopyrimidines
Prior art date: 1998-03-11

Application number

MA25485A

Other languages

English (en)

Inventor

Michael Boes

Claus Riemer

Heinz Stadler

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-11

Filing date

1999-03-08

Publication date

2004-12-20

1999-03-08 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2004-12-20 Publication of MA26612A1 publication Critical patent/MA26612A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

MA25485A 1998-03-11 1999-03-08 Pyrazolopyrimidines et pyrazolotriazines MA26612A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP98104346		1998-03-11

Publications (1)

Publication Number	Publication Date
MA26612A1 true MA26612A1 (fr)	2004-12-20

Family

ID=8231568

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA25485A MA26612A1 (fr)	1998-03-11	1999-03-08	Pyrazolopyrimidines et pyrazolotriazines

Country Status (33)

Country	Link
US (1)	US6194410B1 (fr)
EP (1)	EP0941994B1 (fr)
JP (1)	JP3231288B2 (fr)
KR (1)	KR100313181B1 (fr)
CN (1)	CN1118468C (fr)
AR (1)	AR016453A1 (fr)
AT (1)	ATE240332T1 (fr)
AU (1)	AU752408B2 (fr)
BR (1)	BR9901095A (fr)
CA (1)	CA2265095C (fr)
CZ (1)	CZ291514B6 (fr)
DE (1)	DE69907784T2 (fr)
DK (1)	DK0941994T3 (fr)
ES (1)	ES2198095T3 (fr)
HR (1)	HRP990077B1 (fr)
HU (1)	HUP9900589A1 (fr)
ID (1)	ID23575A (fr)
IL (1)	IL128869A (fr)
MA (1)	MA26612A1 (fr)
MY (1)	MY119536A (fr)
NO (1)	NO312297B1 (fr)
NZ (1)	NZ334526A (fr)
PE (1)	PE20000337A1 (fr)
PL (1)	PL331875A1 (fr)
PT (1)	PT941994E (fr)
RU (1)	RU2218340C2 (fr)
SG (1)	SG78336A1 (fr)
SI (1)	SI0941994T1 (fr)
TR (1)	TR199900531A2 (fr)
TW (1)	TW585865B (fr)
UY (1)	UY25419A1 (fr)
YU (1)	YU12099A (fr)
ZA (1)	ZA991946B (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000059907A2 (fr) *	1999-04-06	2000-10-12	Du Pont Pharmaceuticals Company	Pyrazolotriazines antagonistes de corticoliberine (crf)
DE19956791A1 (de) *	1999-11-25	2001-05-31	Merck Patent Gmbh	Neue Sulfonyloxazolamine
PE20020394A1 (es)	2000-08-18	2002-06-21	Agouron Pharma	Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
ATE355102T1 (de) *	2001-03-13	2006-03-15	Bristol Myers Squibb Pharma Co	4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6- methoxypyrid-3-yl) pyrazolo- 1,5-aö-1,3,5-triazin,seine enantiomeren und pharmazeutisch annehmbare salze als corticotropin-releasing-factor-rezeptor-ligande
SK16052003A3 (en)	2001-06-07	2004-10-05	Hoffmann La Roche	New indole derivatives with 5-HT6 receptor affinity
MXPA03011638A (es)	2001-06-15	2004-04-02	Hoffmann La Roche	Nuevos derivados de 4-piperazinil indol con afinidad por el receptor 5-ht6.
JP2005527463A (ja) *	2001-08-07	2005-09-15	スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー	Ｃｎｓ疾患を治療するための５−ｈｔ６受容体アフィニティーを有する３−アリールスルホニル−７−ピペラジニル−インドール、−ベンゾフランおよび−ベンゾチオフェン
PL210413B1 (pl) *	2001-12-20	2012-01-31	Wyeth Corp	Pochodne indoliloalkiloaminy
US6642381B2 (en) *	2001-12-27	2003-11-04	Hoffman-La Roche Inc.	Pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds as protein tyrosine phosphatase inhibitors
GB0202679D0 (en) *	2002-02-05	2002-03-20	Glaxo Group Ltd	Novel compounds
UA78999C2 (en) *	2002-06-04	2007-05-10	Wyeth Corp	1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
US6875771B2 (en)	2002-07-26	2005-04-05	Bristol-Myers Squibb Company	Pyridopyrimidine derivatives as 5-HT6 antagonists
US7196078B2 (en) *	2002-09-04	2007-03-27	Schering Corpoartion	Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors
PT1537116E (pt) *	2002-09-04	2010-09-03	Schering Corp	Pirazolopirimidinas adequadas para o tratamento de doenças cancerosas
US7329658B2 (en) *	2003-02-06	2008-02-12	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
MXPA05008441A (es) *	2003-02-14	2005-10-19	Wyeth Corp	Derivados de heterociclil-3-sulfonilindazol o azaindazol como ligandos de 5-hidroxitriptamina-6.
AU2004215481B2 (en)	2003-02-28	2010-11-11	Teijin Pharma Limited	Pyrazolo(1,5-A)pyrimidine derivatives
GB0305559D0 (en) *	2003-03-11	2003-04-16	Teijin Ltd	Compounds
US7585881B2 (en) *	2004-02-18	2009-09-08	Astrazeneca Ab	Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
WO2005112936A1 (fr) *	2004-05-14	2005-12-01	The Regents Of The University Of Michigan	Compositions et methodes associees aux inhibiteurs de la proteine kinase
US7528138B2 (en) *	2004-11-04	2009-05-05	Vertex Pharmaceuticals Incorporated	Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases
RU2390523C2 (ru) *	2005-10-21	2010-05-27	Мицубиси Танабе Фарма Корпорейшн	ПРОИЗВОДНОЕ ПИРАЗОЛ[1,5-a]ПИРИМИДИНА
RU2330854C2 (ru) *	2006-03-15	2008-08-10	Государственное образовательное учреждение высшего профессионального образования "Пермская государственная фармацевтическая академия Федерального агентства по здравоохранению и социальному развитию" (ГОУВПО "ПГФА Росздрава")	Способ получения конденсированных гем-диметилзамещенных амино-1,3,5-триазинов
RU2369600C1 (ru) *	2008-01-24	2009-10-10	Андрей Александрович Иващенко	ЗАМЕЩЕННЫЕ 4-СУЛЬФОНИЛ-ПИРАЗОЛЫ И 3-СУЛЬФОНИЛ-ПИРАЗОЛО[1,5-a]ПИРИМИДИНЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ5-HT6 РЕЦЕПТОРОВ, АКТИВНЫЙ КОМПОНЕНТ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ЛЕКАРСТВЕННОЕ СРЕДСТВО И СПОСОБЫ ИХ ПОЛУЧЕНИЯ
EP2248816B1 (fr) *	2008-01-24	2014-10-22	Alla Chem, LLC.	2-alkylamino-3-arylsulfonyl-cyclo-alcano [e ou d]pyrazolo[1,5-a]pyrimidines substituées fonctionnant comme des antagonistes des récepteurs 5-ht6 de sérotonine, procédés de fabrication et d'utilisation
EA017818B1 (ru) *	2008-01-24	2013-03-29	Андрей Александрович ИВАЩЕНКО	ЗАМЕЩЕННЫЕ ЦИКЛОАЛКАНО[e ИЛИ d]ПИРАЗОЛО[1,5-a]ПИРИМИДИНЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-НТРЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
US8309559B2 (en) *	2008-01-24	2012-11-13	Nikolay Filippovich Savchuk	(EN) substituted 2-amino-3-sulfonyl-pyrazolo[1,5-A] pyrimidines/antagonists of serotonin 5-HT6 receptors, methods for the production and the use thereof
RU2384581C2 (ru)	2008-05-07	2010-03-20	Андрей Александрович Иващенко	ЗАМЕЩЕННЫЕ 2-АМИНО-3-СУЛЬФОНИЛ-ТЕТРАГИДРО-ПИРАЗОЛО[1,5-a]ПИРИДО-ПИРИМИДИНЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-HT6 РЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
EP3020719B1 (fr)	2008-10-06	2017-09-20	Alla Chem, LLC.	3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines substituées, antagonistes du récepteur 5-ht6 de sérotonine, procédés de production et d'utilisation associés
EP2384328B1 (fr)	2008-11-27	2013-02-13	Boehringer Ingelheim International GmbH	Derives de 6,7,8,9-tetrahydro-5h-1,4,7,10a-tetraaza-cyclohept[f]indene, compositions pharmaceutiques contenant ces composes, leur utilisation et procede pour leur preaparation
GB0908394D0 (en)	2009-05-15	2009-06-24	Univ Leuven Kath	Novel viral replication inhibitors
GB0913636D0 (en)	2009-08-05	2009-09-16	Univ Leuven Kath	Novel viral replication inhibitors
KR20140003438A (ko)	2010-11-15	2014-01-09	카톨리에케 유니버시테이트 루벤	항바이러스성 축합 헤테로사이클릭 화합물
RU2443697C1 (ru)	2010-12-21	2012-02-27	Александр Васильевич Иващенко	Замещенные метил-амины, антагонисты серотониновых 5-ht6 рецепторов, способы получения и применения
EP2760453B1 (fr)	2011-09-30	2016-05-25	Ipsen Pharma S.A.S.	Inhibiteurs macrocycliques de la kinase lrrk2
PL2834243T3 (pl) *	2012-03-09	2018-09-28	Lexicon Pharmaceuticals, Inc.	Związki na bazie pirazolo[1,5-a]pirymidyny, zawierające je kompozycje i sposoby ich zastosowania
TW201542550A (zh) *	2013-09-06	2015-11-16	Lexicon Pharmaceuticals Inc	吡唑并［１，５－ａ］嘧啶基化合物、包含彼之組合物以及使用彼之方法
TW201620911A (zh) *	2014-03-17	2016-06-16	雷西肯製藥股份有限公司	銜接子關聯激酶１之抑制劑、包含其之組成物、及其使用方法
TR201904514T4 (tr)	2014-09-17	2019-04-22	Oncodesign Sa	Makrosiklik LRRK2 kinaz inhibitörleri.
ES2899196T3 (es)	2015-03-09	2022-03-10	Aurigene Discovery Tech Ltd	Derivados de pirazolo[1,5-a][1,3,5]triazina y de pirazolo[1,5-a]pirimidina como inhibidores de CDK
WO2017052394A1 (fr) *	2015-09-23	2017-03-30	Uniwersytet Jagielloński	Composés d'imidazopyridine et leur utilisation comme ligands du récepteur 5-ht6
HK1256751A1 (zh)	2015-11-02	2019-10-04	Janssen Pharmaceutica Nv	[1，2，4]三唑并[1，5-a]嘧啶-7-基化合物
CN109937202B (zh)	2016-11-02	2022-12-30	詹森药业有限公司	作为pde2抑制剂的[1,2,4]三唑并[1,5-a]嘧啶化合物
MA46690A (fr)	2016-11-02	2019-09-11	Janssen Pharmaceutica Nv	Composés de [1,2,4]triazolo [1,5-a]pyrimidine en tant qu'inhibiteurs de pde2
MY193511A (en)	2016-11-02	2022-10-17	Janssen Pharmaceutica Nv	[1,2,4]triazolo[1,5-a]pyrimidine derivatives as pde2 inhibitors
TW202521536A (zh)	2019-05-05	2025-06-01	美商基尼特奇公司	Ｃｄｋ抑制劑
CN112142744A (zh)	2019-06-28	2020-12-29	上海瑛派药业有限公司	取代的稠合杂芳双环化合物作为激酶抑制剂及其应用
MX2022008627A (es)	2020-01-13	2022-11-08	Verge Analytics Inc	Pirazolo-pirimidinas sustituidas y usos de las mismas.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3907799A (en) *	1971-08-16	1975-09-23	Icn Pharmaceuticals	Xanthine oxidase inhibitors
WO1989000994A2 (fr)	1987-07-31	1989-02-09	E.I. Du Pont De Nemours And Company	Sulfonamides herbicides
US4921527A (en) *	1987-07-31	1990-05-01	E. I. Du Pont De Nemours And Company	Herbicidal sulfonamides
DE3825043A1 (de)	1988-07-20	1990-02-15	Schering Ag	3-methylsulfonyl-pyrazolo(1,5-a)pyrimidin-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider, pflanzenwuchsregulierender und fungizider wirkung
US5571813A (en) *	1993-06-10	1996-11-05	Beiersdorf-Lilly Gmbh	Fused pyrimidine compounds and their use as pharmaceuticals
WO1997011075A1 (fr)	1995-09-22	1997-03-27	Takeda Chemical Industries, Ltd.	Composes de triazole, leur production et utilisation
CA2274055A1 (fr)	1996-12-19	1998-06-25	Smithkline Beecham P.L.C.	Derives du n-piperazine-1-ylphenyl-benzamide
DZ2376A1 (fr)	1996-12-19	2002-12-28	Smithkline Beecham Plc	Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
TR200000073T2 (tr)	1997-07-11	2000-06-21	Smithkline Beecham P.L.C.	5-HT6 Reseptör antagonistleri olan sülfonamid türevleri ve bunların hazırlanma prosesi

1999
- 1999-02-24 US US09/256,927 patent/US6194410B1/en not_active Expired - Fee Related
- 1999-03-03 SI SI9930320T patent/SI0941994T1/xx unknown
- 1999-03-03 ES ES99102872T patent/ES2198095T3/es not_active Expired - Lifetime
- 1999-03-03 DE DE69907784T patent/DE69907784T2/de not_active Expired - Fee Related
- 1999-03-03 PT PT99102872T patent/PT941994E/pt unknown
- 1999-03-03 EP EP99102872A patent/EP0941994B1/fr not_active Expired - Lifetime
- 1999-03-03 AT AT99102872T patent/ATE240332T1/de not_active IP Right Cessation
- 1999-03-03 DK DK99102872T patent/DK0941994T3/da active
- 1999-03-08 YU YU12099A patent/YU12099A/sh unknown
- 1999-03-08 NZ NZ334526A patent/NZ334526A/xx unknown
- 1999-03-08 PE PE1999000183A patent/PE20000337A1/es not_active Application Discontinuation
- 1999-03-08 IL IL12886999A patent/IL128869A/xx not_active IP Right Cessation
- 1999-03-08 CA CA002265095A patent/CA2265095C/fr not_active Expired - Fee Related
- 1999-03-08 MA MA25485A patent/MA26612A1/fr unknown
- 1999-03-09 AR ARP990100990A patent/AR016453A1/es unknown
- 1999-03-09 UY UY25419A patent/UY25419A1/es unknown
- 1999-03-09 MY MYPI99000853A patent/MY119536A/en unknown
- 1999-03-09 JP JP06114999A patent/JP3231288B2/ja not_active Expired - Fee Related
- 1999-03-09 SG SG1999001080A patent/SG78336A1/en unknown
- 1999-03-10 RU RU99105137/04A patent/RU2218340C2/ru active
- 1999-03-10 PL PL99331875A patent/PL331875A1/xx unknown
- 1999-03-10 HU HU9900589A patent/HUP9900589A1/hu not_active Application Discontinuation
- 1999-03-10 ID IDP990198D patent/ID23575A/id unknown
- 1999-03-10 BR BR9901095-0A patent/BR9901095A/pt not_active Application Discontinuation
- 1999-03-10 KR KR1019990007881A patent/KR100313181B1/ko not_active Expired - Fee Related
- 1999-03-10 ZA ZA9901946A patent/ZA991946B/xx unknown
- 1999-03-10 TW TW088103692A patent/TW585865B/zh not_active IP Right Cessation
- 1999-03-10 CZ CZ1999825A patent/CZ291514B6/cs not_active IP Right Cessation
- 1999-03-10 NO NO19991150A patent/NO312297B1/no unknown
- 1999-03-11 AU AU20383/99A patent/AU752408B2/en not_active Ceased
- 1999-03-11 TR TR1999/00531A patent/TR199900531A2/xx unknown
- 1999-03-11 CN CN99105964A patent/CN1118468C/zh not_active Expired - Fee Related
- 1999-03-11 HR HR990077A patent/HRP990077B1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
TW585865B (en)	2004-05-01
PL331875A1 (en)	1999-09-13
ES2198095T3 (es)	2004-01-16
AU752408B2 (en)	2002-09-19
ZA991946B (en)	1999-09-13
AR016453A1 (es)	2001-07-04
IL128869A (en)	2003-09-17
JP3231288B2 (ja)	2001-11-19
US6194410B1 (en)	2001-02-27
CN1236780A (zh)	1999-12-01
PE20000337A1 (es)	2000-05-13
DK0941994T3 (da)	2003-09-08
HRP990077A2 (en)	2000-02-29
CZ291514B6 (cs)	2003-03-12
CZ82599A3 (cs)	1999-09-15
HUP9900589A1 (hu)	2000-03-28
HK1023343A1 (en)	2000-09-08
SI0941994T1 (en)	2003-10-31
EP0941994B1 (fr)	2003-05-14
DE69907784T2 (de)	2004-03-25
NO312297B1 (no)	2002-04-22
JP2000186090A (ja)	2000-07-04
HU9900589D0 (en)	1999-05-28
NZ334526A (en)	2000-07-28
NO991150D0 (no)	1999-03-10
TR199900531A3 (tr)	1999-10-21
CN1118468C (zh)	2003-08-20
RU2218340C2 (ru)	2003-12-10
UY25419A1 (es)	2001-11-30
MY119536A (en)	2005-06-30
IL128869A0 (en)	2000-01-31
KR19990077741A (ko)	1999-10-25
KR100313181B1 (ko)	2001-11-05
BR9901095A (pt)	2000-05-02
HRP990077B1 (en)	2003-08-31
DE69907784D1 (de)	2003-06-18
SG78336A1 (en)	2001-02-20
TR199900531A2 (xx)	1999-10-21
NO991150L (no)	1999-09-13
CA2265095C (fr)	2008-07-22
YU12099A (sh)	2000-10-30
AU2038399A (en)	1999-09-23
ID23575A (id)	2000-05-04
CA2265095A1 (fr)	1999-09-11
ATE240332T1 (de)	2003-05-15
EP0941994A1 (fr)	1999-09-15
PT941994E (pt)	2003-09-30

Publication	Publication Date	Title
MA26612A1 (fr)	2004-12-20	Pyrazolopyrimidines et pyrazolotriazines
DE69836432D1 (de)	2006-12-28	Bildcoder und -decoder
ID21031A (id)	1999-04-08	Kornea buatan
ATE220304T1 (de)	2002-07-15	Servier- und transportaufnahme
BR9506832A (pt)	1997-10-14	N-pirazolilanilinas e n-pirazolilaminopiridinas
ID23083A (id)	2000-02-03	Popok sekali pakai
DE69916694D1 (de)	2004-06-03	2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on
ID23258A (id)	2000-04-05	Penarik pemberian-menyilang dan metodenya
DK1140952T3 (da)	2004-01-12	Phosphororganiske forbindelser og anvendelse heraf
EE9900019A (et)	1999-08-16	Asolotriasiinid ja -pürimidiinid
FI974044A0 (fi)	1997-10-24	Spis
NO974125D0 (no)	1997-09-08	N-benzylazoliumderivater
DE69733555D1 (de)	2005-07-21	INTEGRIERTES dE-E-DETEKTORTELESKOP
FI972010A0 (fi)	1997-05-13	Arrangemang i en borrningsanordning
FI980680L (fi)	1999-09-27	Rakenne ja sen käyttö
DE59812220D1 (de)	2009-06-04	Halte- und trageband
FI980691A0 (fi)	1998-03-26	Xylitoltillsats i roektobak
DE59711480D1 (de)	2004-05-06	Küvettenanordnung
FI974109A0 (fi)	1997-10-31	Arrangemang i en lindningsanordning
BR7603138U (pt)	1998-09-22	Prática e única
IT245168Y1 (it)	2002-03-19	Strutture e ritmi
KR970056392U (ko)	1997-10-13	배지구조
ITMI941026A1 (it)	1995-11-21	Azaciclo e azabiciclo ammidi
BA98291A (bs)	2000-11-06	Epoksi-azetidinoni priprava i upotreba
UA1419S (uk)	1997-02-28	Знак розрізнення